Elicio Therapeutics Inc. (ELTX) — Capital Reinvestment Ratio
Latest as of June 2022:
0.09x
Elicio Therapeutics Inc. (ELTX) has a Capital Reinvestment Ratio of 0.09x as of June 2022, meaning it reinvests 0% of its operating cash flow ($6.14 Million) in capital expenditures ($559.00K). See Elicio Therapeutics Inc. free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.09x
Capex / Operating Cash Flow
Operating Cash Flow
$6.14 Million
USD
Capital Expenditures
$559.00K
USD
Data as of
Jun 2022
Most recent filing
Elicio Therapeutics Inc. Capital Reinvestment Ratio (2012–2013)
This chart tracks Elicio Therapeutics Inc.'s Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Elicio Therapeutics Inc. (2012–2013)
Year-by-year Capital Reinvestment Ratio for Elicio Therapeutics Inc. from 2012 to 2013. For live market cap and broader valuation context, see Elicio Therapeutics Inc. (ELTX) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2013 | 0.01x | $1.89 Million | $17.57K | ▼ -79.3% |
| 2012 | 0.04x | $1.07 Million | $47.73K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow